SEC Form 4 · accession 0001572426-15-000123
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Gearing
Officer — Chief Scientific Officer
Period of report
Nov 5, 2015
Accepted (ET)
Nov 5, 2015 · 1:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Nov 5, 2015 | M | 9,204 | $0.125 | A | 273,730 | I | By Gearing Family Pty Ltd <Gearing Family A/C> |
| Ordinary Shares | holding | — | — | — | 5,600 | D | ||
| Ordinary SharesF1 | holding | — | — | — | 83,664 | I | By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C> |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase sharesF1,F2 | $0.125 | Nov 5, 2015 | M | 9,204 | D | Nov 5, 2015 | Nov 5, 2023 | Ordinary Shares | 9,204 | 9,203 | I |
Explanation of responses
- F1The reporting person and his spouse have shared voting and dispositive power with respect to these reported securities.
- F29,204 options vested and became exercisable on 11/5/15; a further 9,203 options will vest and be exercisable on 11/5/16.